Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma

Histology and Histopathology

Volumn 26, Issue 9, 2011, Pages 1165-1172

  Deron, Philippe ^a   Vermeersch, Hubert ^a   Mees, Gilles ^a   Vangestel, Christel ^a   Pauwels, Patrick ^a   van de Wiele, Christophe ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Glucose transporter; Hexokinase; Prognosis; Squamous cell carcinoma; Tonsil and mobile tongue

Indexed keywords

GLUCOSE TRANSPORTER; HEXOKINASE; SLC5A1 PROTEIN, HUMAN; SODIUM GLUCOSE COTRANSPORTER 1; TUMOR MARKER;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BIOSYNTHESIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; OROPHARYNX TUMOR; PALATINE TONSIL; PATHOLOGY; PHARYNX CANCER; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HEXOKINASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PALATINE TONSIL; PHARYNGEAL NEOPLASMS; PROGNOSIS; SODIUM-GLUCOSE TRANSPORTER 1; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 80053188663     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Burstein D.E., Nagi C., Kohtz D.S., Lee L. and Wang B. (2006). Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization. Histopathology 48, 717-722.
2. Casneuf V., Fonteyne P., Van Damme N., Demetter P., Pauwels P., de Hemptinne B. de Vos M., van de Wiele C. and Peeters M. (2008). Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival. Cancer Invest. 26, 852-859.
3. Choi Y.S., Kim S.J., Kim D.S., Park S.J., Park Y., Shin H.J., Jung K.Y., Baek S.K., Shin B.K., Choi J.W., Kim B.S., Shin S.W., Kim Y.H. and Kim J.S. (2007). Glucose transporter-1 expression in squamous cell carcinoma of the tongue. Cancer Res. Treat. 39, 109-115.
4. De Vicente J.C., Reico O.R., Pendas S.L. and Lopez-Arranz J.S. (2001). Oral squamous cell carcinoma of the mandibular region: A survival study. Head Neck 23, 536-543.
5. Eckert A.W., Lautner M.H., Taubert H., Schubert J. and Bilkenroth U. (2008). Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients. Oncol. Rep. 20, 1381-1385.
6. Fonteyne P., Casneuf V., Pauwels P., Van Damme N., Peeters M., Dierickx R. and van de Wiele C. (2009). Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma. Histol. Histopathol. 24, 971-977.
7. Fu Y., Maianu L., Melbert B.R. and Garvey W.T. (2004). Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1,3, and 5 in the immune response and foam cell formation. Blood Cells Mol. Dis. 32, 182-190.
8. Heber D., Byerley L.O. and Tchekmedyian N.S. (1992). Hormonal and metabolic abnormalities in the malnourished cancer patient: effects on host tumour interaction. J. Parenter. Enteral. Nutr. 16 (6 suppl), 60S-64S.
9. Helmke B.M., Reisser C., Idzko M., Dyckhoff G. and Herold-Mende C. (2003). Expression of SGLT-1 in preneoplastic and neoplastic lesions of the head and neck. Oral Oncol. 40, 28-35.
10. Hoogsteen I.J., Marres H.A., Bussink J., van der Kogel A.J. and Kaanders J.H. (2007). Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review. Head Neck 29, 591-604.
11. Jonathan R.A., Wijffels K.I., Peeters W., de Wilde P.C., Marres H.A., Merckx M.A., Oosterwijk E., van der Kogel A.J. and Kaanders J.H. (2006). The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother. Oncol. 79, 288-297.
12. Joost H.G. and Thorens B. (2001). The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol. Membr Biol 18, 247-256.
13. Kallinowski F., Schlenger K.H., Runkel S., Kloes M., Stohrer M., Okunieff P. and Vaupel P. (1989). Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res. 49, 3759-3764.
14. Kunkel M., Reichert T.E., Benz P., Lehr H.A., Jeong J.H., Wieand S., Bartenstein P., Wagner W. and Whiteside T.L. (2003). Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97, 1015-1024.
15. Kunkel M., Moergel M., Stockinger M., Jeong J.H., Fritz G., Lehr H.A. and Whiteside T.L. (2007). Over-expression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity. Oral Oncol. 43, 796-803.
16. Li S.J., Guo W., Ren G.X., Huang G., Chen T. and Song S.L. (2008). Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2- deoxy-D-glucose accumulation in positron emission tomography. Br. J. Oral. Maxillofac. Surg. 46, 180-186.
17. Lo W.L., Kao S.Y., Chi L.Y., Wong Y.K. and Chang RC. (2003). Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J. Oral. Maxillofac. Surg. 61, 751-758.
18. Macheda M.L., Rogers S. and Best J.D. (2005). Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 202, 654-662.
19. Mellanen P., Minn H., Grénman R. and Härkönen P. (1994). Expression of glucose transporters in head-and-neck tumors. Int. J. Cancer 56, 622-629.
20. Pedersen P.L., Mathupala S., Rempel A., Geschwind J.F. and Ko Y.H. (2002). Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim. Biophys. Acta 1555,14-20.
21. Reisser C., Eichhorn K., Herold-Mende C., Born A.I. and Bannasch P. (1999). Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck. Int. J. Cancer 80, 194-198.
22. Roh J.L., Cho K.J., Kwon G.Y., Ryu C.H., Chang H.W., Choi S.H., Nam S.Y. and Kim S.Y. (2009). The prognostic value of hypoxia markers in T2-staged oral tongue cancer. Oral. Oncol. 45, 63-68.
23. Scheepers A., Joost H.G. and Schürmann A. (2004). The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. J. Parenter. Enteral. Nutr. 28, 364-371.
24. Schrijvers M.L., van der Laan B.F., de Bock G.H., Pattje W.J., Mastik M.F., Menkema L., Langendijk J.A., Kluin P.M., Schuuring E. and van der Wal J.E. (2008). Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy. Int. J. Radiat. Oncol. Biol.Physiol. 72, 161-169.
25. Smith T.A. (2000). Mammalian hexokinases and their expression in cancer. Br. J. Biomed. Sci. 57, 170-178.
26. Tian M., Zhang H., Higuchi T., Oriuchi N., Nakasone Y., Takata K., Nakajima N., Mogi K. and Endo K. (2005). Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging. Ann. Nucl. Med. 19, 335-338.
27. Tsao T., Li J., Chang K., Stenbit A., Galuska D., Anderson E., Zierath J., McCarter R., Charron M (2001). Metabolic adaptations in skeletal muscle overexpressing GLUT4: effects on muscle and physical activity. FASEB J. 15, 958-969.
28. Warburg O. (1956). On the origin of cancer cells. Science. 123, 309-314.
29. Wood I.S. and Trayhorn P. (2003). Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br. J. Nutrition. 89, 3-9.
30. Zhou S., Wang S., Wu Q., Fan J. and Wang Q. (2008). Expression of glucose transporter-1 and -3 in the head and neck carcinoma - the correlation of the expression with the biological behaviors. ORL J. Otorhinolaryngol. Relat. Spec. 70, 189-194.